0000899243-22-020935.txt : 20220603
0000899243-22-020935.hdr.sgml : 20220603
20220603160540
ACCESSION NUMBER: 0000899243-22-020935
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220601
FILED AS OF DATE: 20220603
DATE AS OF CHANGE: 20220603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAKIANATHAN DEEPIKA
CENTRAL INDEX KEY: 0001270734
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36644
FILM NUMBER: 22994325
MAIL ADDRESS:
STREET 1: 160 BOVET ROAD, SUITE 408
STREET 2: C/O DELPHI VENTURES
CITY: SAN MATEO
STATE: CA
ZIP: 94402
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Calithera Biosciences, Inc.
CENTRAL INDEX KEY: 0001496671
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272366329
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 343 OYSTER POINT BLVD #200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-870-1000
MAIL ADDRESS:
STREET 1: 343 OYSTER POINT BLVD #200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-01
0
0001496671
Calithera Biosciences, Inc.
CALA
0001270734
PAKIANATHAN DEEPIKA
C/O DELPHI VENTURES
63 BOVET RD., SUITE 351
SAN MATEO
CA
94402
1
0
0
0
Stock Option (Right to Buy)
0.20
2022-06-01
4
A
0
20000
0.00
A
2032-05-31
Common Stock
20000
20000
D
1/12 of the Option vests in each monthly installment as measured from June 1, 2022, until the earlier of the Option's full vesting or the reporting person ceasing to provide continuous service to the issuer. In addition, in the event of a Change in Control or a Corporate Transaction (each as defined in the plan pursuant to which the Option was granted), any unvested portion of the Option will fully vest and become exercisable as of immediately prior to the effective time of such Change in Control or Corporate Transaction, subject to the reporting person's continuous service on the effective date of such transaction.
Pursuant to the Delphi Management Partners, VIII, L.L.C. ("DMP VIII") LLC Agreement, the Reporting Person is deemed to hold the options for the benefit of DMP VIII, which is entitled to hold the shares upon issuance. DMP VIII may be deemed the indirect beneficial owner of such shares, and the Reporting Person is a managing member of DMP VIII and may be deemed to share voting and dispositive power over shares held by DMP VIII. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
/s/ Deepika Pakianathan
2022-06-03